James Schoeneck

James Schoeneck

Chairman at KYNTRA BIO, INC.

Net worth: 289 330 $ as of 31/05/2026

68 year
Health Technology
Consumer Services
Commercial Services

Profile

James A. Schoeneck is a businessperson who has been at the head of 5 different companies. Presently, Mr. Schoeneck holds the position of Chairman of FibroGen, Inc. He is also on the board of Calidi Biotherapeutics, Inc. In his past career James A. Schoeneck occupied the position of Chief Executive Officer of BrainCells, Inc., President, Chief Executive Officer & Director at Assertio Therapeutics, Inc., Chief Executive Officer of ActivX Biosciences, Inc., President, Chief Executive & Operating Officer at Prometheus Laboratories, Inc., Vice President & General Manager-Immunology at Centocor, Inc., Principal at KYORIN Pharmaceutical Co., Ltd. and Director-Marketing & Product Group at Rhone-Poulenc Rorer, Inc. James A. Schoeneck received an undergraduate degree from Jacksonville State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2026 39,666 ( 0.98% ) 273 695 $ 31/05/2026
17/04/2026 84,514 ( 2.36% ) 15 635 $ 31/05/2026

James Schoeneck active positions

CompaniesPositionStart
KYNTRA BIO, INC. Chairman 06/01/2020
CALIDI BIOTHERAPEUTICS, INC. Chairman 01/04/2025
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 22/07/2025
Director/Board Member 01/07/2020

Former positions of James Schoeneck

CompaniesPositionEnd
ANAPTYSBIO, INC. Director/Board Member 19/03/2018
Chief Executive Officer 28/03/2017
Chief Executive Officer 01/01/2011
Chief Executive Officer 01/12/2004
Chief Executive Officer 01/01/2003
See the detail of James Schoeneck's experience

Training of James Schoeneck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. James Schoeneck
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!